Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | RECQL | P46063 | 4/20 | 0.42 |
| ▸ | CD38 | P28907 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.42 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.40 |
| ▸ | FTO | Q9C0B1 | 3/20 | 0.40 |
| ▸ | PIM1 | P11309 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | APEX1 | P27695 | 3/20 | 0.40 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.40 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30148687 | 0.72 | EPHX2 (0.54) | MEN1KMT2ARECQLTDP1KDM4E | |
| SCHEMBL219729 | 0.69 | BCL9 (0.49) | MEN1KMT2ARECQLCD38TDP1 | |
| SCHEMBL8934619 | 0.67 | MEN1 (0.47) | MEN1KMT2ARECQLCD38TDP1 | |
| SCHEMBL30422441 | 0.66 | HPGD (0.56) | MEN1KMT2ARECQLTDP1KDM4E | |
| SCHEMBL5941127 | 0.66 | HPGD (0.56) | MEN1KMT2ARECQLTDP1KDM4E | |
| SCHEMBL28068547 | 0.62 | LCK (0.44) | MEN1KMT2ARECQLTDP1MAPK8 | |
| SCHEMBL1880963 | 0.61 | MEN1 (0.66) | MEN1KMT2ARECQLCD38TDP1 | |
| SCHEMBL12639983 | 0.60 | MEN1 (0.74) | MEN1KMT2ARECQLCD38TDP1 | |
| SCHEMBL12639988 | 0.60 | MEN1 (0.61) | MEN1KMT2ARECQLCD38TDP1 | |
| SCHEMBL3066182 | 0.60 | MEN1 (0.78) | MEN1KMT2ARECQLCD38TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4622686-A1 | SPRAY PATCH COMPOSITION, PROCESS FOR PREPARING IT AND KIT | Fondazione Istituto Italiano di Tecnologia (IT) | 2025-10-01 | — | — | EP | claimed |
| WO-2024110911-A1 | SPRAY PATCH COMPOSITION, PROCESS FOR PREPARING IT AND KIT | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2024-05-30 | — | — | WO | claimed |
| EP-4622686-A1 | SPRAY PATCH COMPOSITION, PROCESS FOR PREPARING IT AND KIT | Fondazione Istituto Italiano di Tecnologia (IT) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024110911-A1 | SPRAY PATCH COMPOSITION, PROCESS FOR PREPARING IT AND KIT | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2024-05-30 | — | — | WO | disclosed |
| EP-4309512-A1 | ONE SHOT PROCESS FOR THE SIMULTANEOUS EXTRACTION OF PHYTOCOMPLEX FROM AGRO-INDUSTRIAL PROCESSING WASTE AND LOADING IN EXTRACTIVE VESICLES AND THEIR USE | Argiolas S.p.A. (IT) | 2024-01-24 | — | — | EP | disclosed |
| US-20230332145-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | FLAGSHIP PIONEERING, INC. (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230167450-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | FLAGSHIP PIONEERING, INC. (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230158156-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | FLAGSHIP PIONEERING, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230056888-A1 | COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS VASORELAXANT | EVONIK OPERATIONS GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-20230037453-A1 | PREPARATION FOR USE AS VASORELAXANT | EVONIK OPERATIONS GMBH (DE) | 2023-02-09 | — | — | US | disclosed |
| EP-4125437-A1 | PREPARATION FOR USE AS VASORELAXANT | Evonik Operations GmbH (DE) | 2023-02-08 | — | — | EP | disclosed |
| EP-4125438-A1 | PREPARATION FOR USE AS ANTIOXIDANT | Evonik Operations GmbH (DE) | 2023-02-08 | — | — | EP | disclosed |
| US-20230014918-A1 | COMPOSITIONS FOR USE AS ANTIOXIDANT | EVONIK OPERATIONS GMBH (DE) | 2023-01-19 | — | — | US | disclosed |
| EP-4076010-A1 | COMPOSITIONS FOR USE AS ANTIOXIDANT | Evonik Operations GmbH (DE) | 2022-10-26 | — | — | EP | disclosed |
| EP-4076475-A1 | COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS VASORELAXANT | Evonik Operations GmbH (DE) | 2022-10-26 | — | — | EP | disclosed |
| US-20220105017-A1 | TOPICAL MACQUI BERRY FORMULATION | TRACIE MARTYN INT INC (US) | 2022-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230056888-A1 | COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS VASORELAXANT | GALR3, GALR2, PDE3A | MEN1 3815/4885KMT2A 2516/4885RECQL 3835/4885 |
| US-20230158156-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | EFTUD2, SNRPE, DDX21 | MEN1 2981/4885KMT2A 3463/4885RECQL 633/4885 |
| US-20230332145-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | EFTUD2, DDX21, SNRPE | MEN1 3415/4885KMT2A 3085/4885RECQL 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.